Back to board

Clinical Development Lead (MD), Pulmovant

Pulmovant · United States · US

Clinical Research
Remote
physician
Demand85
Career growth80
Healthcare fit78
Remote potential20
5-year outlook
Senior Director-level biopharma clinical development roles typically offer strong total compensation with potential for VP/clinical program leadership; exact figures depend on company stage, location, and equity.
Clinical license
Not required
Applicant reach
narrow
Seniority
senior
Employment type
full-time
Date found
2026-10-02

Intelligence details

Flexible work details

Engagement type
Permanent
Hours
Full-time
Eligible countries
United States
Profession fit
physician
Rate period
Annual

Listing via Himalayas.

Eligibility, licensing, and location restrictions can change. Always confirm details on the source posting before applying.

Why this is worth applying to

Worth applying for physician-scientists with prior clinical trial/industry experience who want a senior biopharma clinical development leadership role. Not practical for early-career clinicians or those without pharma/Phase 3 experience.

Who should apply

MD/physician-scientists with pulmonary, critical care, or ILD experience; prior pharma/biotech clinical development or medical monitoring experience; track record in Phase 3 trial design/execution, KOL engagement, and regulatory interactions.

CV angle

Frame MD and board certification, then quantify clinical trial leadership: protocol design, Phase 3 execution, site activation, recruitment, data review, safety reporting, GCP compliance, regulatory submissions, and KOL/Health Authority interactions. Highlight pulmonary hypertension/ILD therapeutic expertise and cross-functional team leadership.

Skills to highlight

  • Clinical trial design
  • Phase 3 trial execution
  • Protocol development
  • GCP compliance
  • Regulatory interactions
  • KOL engagement
  • Medical monitoring
  • Data interpretation
  • Cross-functional leadership
  • Pulmonary hypertension/ILD

Role summary

Senior physician leader at Pulmovant/Roivant responsible for clinical development of mosliciguat in PH-ILD, including Phase 3 trial design, execution, medical oversight, and regulatory/KOL strategy.

We publish our own intelligence summary, never the full job description. Always confirm details with the employer when you apply.